Cargando…

Identification of Activated Protein Kinase Cα (PKCα) in the Urine of Orthotopic Bladder Cancer Xenograft Model as a Potential Biomarker for the Diagnosis of Bladder Cancer

Bladder cancer has a high recurrence rate; therefore, frequent and effective monitoring is essential for disease management. Cystoscopy is considered the gold standard for the diagnosis and continuous monitoring of bladder cancer. However, cystoscopy is invasive and relatively expensive. Thus, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawano, Takahito, Tachibana, Yoko, Inokuchi, Junichi, Kang, Jeong-Hun, Murata, Masaharu, Eto, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430461/ https://www.ncbi.nlm.nih.gov/pubmed/34502182 http://dx.doi.org/10.3390/ijms22179276

Ejemplares similares

Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
por: Kawano, Takahito, et al.
Publicado: (2022)

Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials
por: Kawano, Takahito, et al.
Publicado: (2021)

Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts
por: Jäger, Wolfgang, et al.
Publicado: (2014)

Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts
por: Vallo, Stefan, et al.
Publicado: (2016)

Reduction of protein kinase C α (PKC-α) promote apoptosis via down-regulation of Dicer in bladder cancer
por: Jiang, Zhenming, et al.
Publicado: (2015)

Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients
por: Igami, Ko, et al.
Publicado: (2022)

PKC α regulates netrin-1/UNC5B-mediated survival pathway in bladder cancer
por: Liu, Jiao, et al.
Publicado: (2014)

Exploring the five different genes associated with PKCα in bladder cancer based on gene expression microarray
por: Zhang, Xiaotong, et al.
Publicado: (2021)

Tumor Establishment Features of Orthotopic Murine Bladder Cancer Models
por: Lee, Jin Seok, et al.
Publicado: (2012)

Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach
por: Jäger, Wolfgang, et al.
Publicado: (2013)

Orthotopic neobladder after cystectomy for bladder cancer
por: KAKIZOE, Tadao
Publicado: (2020)

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft
por: Inamoto, Teruo, et al.
Publicado: (2015)

Establishment of an optimized orthotopic bladder cancer model in mice
por: Cai, Jinming, et al.
Publicado: (2022)

An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
por: Huebner, Doreen, et al.
Publicado: (2017)

Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007)

Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model
por: Xiao, Zhengwen, et al.
Publicado: (2011)

PKCα and PKCδ: Friends and Rivals
por: Black, Jennifer D., et al.
Publicado: (2022)

An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer
por: Naito, Tomoharu, et al.
Publicado: (2020)

Tumor and Microenvironment Modification during Progression of Murine Orthotopic Bladder Cancer
por: Tham, Sin Mun, et al.
Publicado: (2011)

Integrin αVβ(3)-targeted SPECT/CT for the assessment of Bevacizumab therapy in orthotopic lung cancer xenografts
por: Chen, Bin, et al.
Publicado: (2018)

Urine Telomerase for Diagnosis and Surveillance of Bladder Cancer
por: Lamarca, Angela, et al.
Publicado: (2012)

Shedding Light on Bladder Cancer Diagnosis in Urine
por: Chan, Kit Man, et al.
Publicado: (2020)

Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine
por: Tsukahara, Shigehiro, et al.
Publicado: (2022)

Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma
por: Inokuchi, Junichi, et al.
Publicado: (2019)

Wirelessly Activated Nanotherapeutics for In Vivo Programmable Photodynamic‐Chemotherapy of Orthotopic Bladder Cancer
por: Sun, Bowen, et al.
Publicado: (2022)

CXCL1 is elevated in the urine of bladder cancer patients
por: Burnier, Andre, et al.
Publicado: (2015)

Bladder cancer recurrence surveillance by urine metabolomics analysis
por: Loras, A., et al.
Publicado: (2018)

Multiple Chromatographic Analysis of Urine in the Detection of Bladder Cancer
por: Džubinská, Daniela, et al.
Publicado: (2021)

Detecting and monitoring bladder cancer with exfoliated cells in urine
por: Li, Nannan, et al.
Publicado: (2022)

Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder
por: Zheng, Jin, et al.
Publicado: (2017)

Radical Cystectomy and Orthotopic Bladder Substitution Using Ileum
por: Park, Jinsung, et al.
Publicado: (2011)

Orthotopic bladder substitution: Surgical aspects and optimization of outcomes
por: Thakare, N., et al.
Publicado: (2021)

PKCα expression is a marker for breast cancer aggressiveness
por: Lønne, Gry Kalstad, et al.
Publicado: (2010)

Increase in PKCα Activity during Heart Failure Despite the Stimulation of PKCα Braking Mechanism
por: Aslam, Naveed
Publicado: (2020)

Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model
por: Falke, J., et al.
Publicado: (2018)

Catarrh of the Bladder; Albumen in the Urine
por: Thompson, Henry
Publicado: (1880)

AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms()()
por: Kopsiaftis, Stavros, et al.
Publicado: (2016)

Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis
por: Roth, Beat, et al.
Publicado: (2016)

Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples
por: Piatti, Paolo, et al.
Publicado: (2021)

Detection of Bladder Cancer Using Proteomic Profiling of Urine Sediments
por: Majewski, Tadeusz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uv2464pk5i7ej9u8feflut62cc